Jaguar Health, Inc. (JAGX) Form S-3/A — Nov 3, 2026
Jaguar Health filed Amendment No. 1 to its Form S-3 shelf registration statement, registering up to $75,000,000 of common stock, preferred stock, warrants, subscription rights and units for sale from time to time. The amendment carries forward $41,376,058.50 of unsold securities from the company's prior effective S-3 (File No. 333-278861) under Rule 415(a)(6) and registers $33,623,941.50 of new capacity.
Key figures
- Offering Price
- 0.8841
- Total Shelf Capacity
- 75000000
- Net fee due
- 15.93
- Series r conversion ratio
- 1 preferred share to 5 common shares
- Last reported sale price date
- 2026-11-02
- Shares outstanding after series r conversion
- 13345986
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.